585 related articles for article (PubMed ID: 20456733)
61. Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High-Risk Cardiovascular Disease.
Okere AN; Serra C
Pharmacotherapy; 2015 Aug; 35(8):771-9. PubMed ID: 26256279
[TBL] [Abstract][Full Text] [Related]
62. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
[TBL] [Abstract][Full Text] [Related]
63. Achievement of English National Service Framework lipid-lowering goals: pooled data from recent comparative treatment trials of statins at starting doses.
Hobbs FD; Southworth H
Int J Clin Pract; 2005 Oct; 59(10):1171-7. PubMed ID: 16178985
[TBL] [Abstract][Full Text] [Related]
64. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
65. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Sullivan D; Olsson AG; Scott R; Kim JB; Xue A; Gebski V; Wasserman SM; Stein EA
JAMA; 2012 Dec; 308(23):2497-506. PubMed ID: 23128163
[TBL] [Abstract][Full Text] [Related]
66. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
[TBL] [Abstract][Full Text] [Related]
67. Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.
Awad K; Mikhailidis DP; Toth PP; Jones SR; Moriarty P; Lip GYH; Muntner P; Catapano AL; Pencina MJ; Rosenson RS; Rysz J; Banach M;
Cardiovasc Drugs Ther; 2017 Aug; 31(4):419-431. PubMed ID: 28741244
[TBL] [Abstract][Full Text] [Related]
68. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.
Zhang X; Xing L; Jia X; Pang X; Xiang Q; Zhao X; Ma L; Liu Z; Hu K; Wang Z; Cui Y
Cardiovasc Ther; 2020; 2020():3987065. PubMed ID: 32411300
[TBL] [Abstract][Full Text] [Related]
69. Treating hypercholesterolemia: looking forward.
Gotto AM
Clin Cardiol; 2003 Jan; 26(1 Suppl 1):I21-8. PubMed ID: 12539819
[TBL] [Abstract][Full Text] [Related]
70. Statins: within-group comparisons, statin escape and combination therapy.
Tikkanen MJ
Curr Opin Lipidol; 1996 Dec; 7(6):385-8. PubMed ID: 9117143
[TBL] [Abstract][Full Text] [Related]
71. Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment.
Schectman G; Hiatt J
Ann Intern Med; 1996 Dec; 125(12):990-1000. PubMed ID: 8967711
[TBL] [Abstract][Full Text] [Related]
72. Expanded table: statins.
Med Lett Drugs Ther; 2019 Sep; 61(1581):e152. PubMed ID: 31599870
[No Abstract] [Full Text] [Related]
73. [Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review].
Kızılırmak P; Öngen Z; Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2020 Mar; 48(2):137-148. PubMed ID: 32147651
[TBL] [Abstract][Full Text] [Related]
74. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
75. Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
Lu Y; Cheng Z; Zhao Y; Chang X; Chan C; Bai Y; Cheng N
Atherosclerosis; 2016 Nov; 254():215-227. PubMed ID: 27764723
[TBL] [Abstract][Full Text] [Related]
76. The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis.
Scholle JM; Baker WL; Talati R; Coleman CI
J Am Coll Nutr; 2009 Oct; 28(5):517-24. PubMed ID: 20439548
[TBL] [Abstract][Full Text] [Related]
77. The effect of statins on erectile dysfunction: a meta-analysis of randomized trials.
Kostis JB; Dobrzynski JM
J Sex Med; 2014 Jul; 11(7):1626-35. PubMed ID: 24684744
[TBL] [Abstract][Full Text] [Related]
78. Efficacy and safety of pitavastatin versus simvastatin: a meta-analysis of randomized controlled trials.
Jiang Z; Gong RR; Qiu L; Wang Q; Su M; Liu XJ; Hu MS; Lin J; Fang DZ
Clin Drug Investig; 2014 Sep; 34(9):599-608. PubMed ID: 25022719
[TBL] [Abstract][Full Text] [Related]
79. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
80. Meta-Analysis of Usefulness of Psyllium Fiber as Adjuvant Antilipid Therapy to Enhance Cholesterol Lowering Efficacy of Statins.
Brum J; Ramsey D; McRorie J; Bauer B; Kopecky SL
Am J Cardiol; 2018 Oct; 122(7):1169-1174. PubMed ID: 30078477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
